SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Applied DNA Sciences Inc. – APDN

NEW YORK, NY / ACCESSWIRE / October 30, 2015 / Pomerantz LLP is investigating claims on behalf of investors of Applied DNA Sciences Inc. (“Applied DNA” or the “Company”) (NASDAQ: APDN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Applied DNA and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On October 29, 2015, The Pump Stopper published an article that described the company as “one of the worst retail-shareholder wipeout machines I have ever seen.” Among other information, the article detailed the company’s “Valeant-esque” relationship with an opaque UK entity, use of paid stock promotion, and obsolete product base.

On this news, the company’s stock has plunged by $3.41, or nearly 49%, during intraday trading on October 29, 2015.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 433121